ARCHIVES

Three Cancer Centers Test Targeted Therapy For Resistant Acute Myelogenous Leukemia

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978

Public Health Service: Blumenthal Transferred to Surgeon General’s office, HHS Says

November 7, 1997

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Senate Subcommittee Okays $1 billion For NCI In FY 1980, Agrees To Block Obey Reprogramming

June 15, 1979

Free Standing Cancer Center Firms Expanding Markets

February 21, 1986